SCHEMBL5196690

SCHEMBL5196690

CCOC(=O)COc1ccc(C(=O)O)c(Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.57
GAA P10253 5/20 0.52
KDM4E B2RXH2 5/20 0.52
HSD17B10 Q99714 4/20 0.52
NPSR1 Q6W5P4 2/20 0.51
MAPT P10636 5/20 0.49
ALDH1A1 P00352 4/20 0.49
TP53 P04637 2/20 0.49
CASP3 P42574 1/20 0.49
CASP7 P55210 1/20 0.49
CASP9 P55211 1/20 0.49
MCL1 Q07820 1/20 0.49
GLA P06280 1/20 0.48
MAPK1 P28482 1/20 0.48
LMNA P02545 2/20 0.47
CASP1 P29466 1/20 0.47
POLB P06746 1/20 0.47
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5066833 0.89 HPGD (0.54) HPGDGAAKDM4EHSD17B10NPSR1
SCHEMBL25143181 0.85 HPGD (0.60) HPGDGAAKDM4EHSD17B10NPSR1
SCHEMBL903954 0.85 GAA (0.57) HPGDGAAKDM4EHSD17B10NPSR1
SCHEMBL5032922 0.85 KDM4E (0.53) HPGDKDM4EHSD17B10MAPTALDH1A1
SCHEMBL13744660 0.84 GAA (0.56) HPGDGAAKDM4EHSD17B10NPSR1
SCHEMBL5195851 0.83 HPGD (0.49) HPGDGAAKDM4EHSD17B10NPSR1
SCHEMBL7486777 0.82 HPGD (0.56) HPGDGAAKDM4EHSD17B10NPSR1
SCHEMBL27527261 0.81 HPGD (0.54) HPGDNPSR1MAPTLMNAMEN1
SCHEMBL5531605 0.81 GAA (0.53) HPGDGAAKDM4EHSD17B10NPSR1
SCHEMBL6458038 0.81 HSD17B10 (0.53) HPGDGAAKDM4EHSD17B10NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 US disclosed
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 US disclosed
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 US disclosed
EP-1813603-A1 AROMATIC AMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICAL USES OF BOTH Kissei Pharmaceutical Co., Ltd. (JP) 2007-08-01 EP disclosed
EP-1813603-A1 AROMATIC AMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICAL USES OF BOTH Kissei Pharmaceutical Co., Ltd. (JP) 2007-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both AVPR2, AVPR1A, AVPR1B HPGD 974/4885GAA 2544/4885KDM4E 3094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.